PLRZ

$0.00

(

0.00%

) Quote details
Add to Watchlist Run Backtest
stock

Polyrizon Ltd. Ordinary Shares

NASDAQ | PLRZ

1.13

USD

$0.00

(

0.00%

)

At Close (As of Oct 14, 2025)

$7.07M

Market Cap

-

P/E Ratio

-0.2

EPS

$1,200.00

52 Week High

$0.55

52 Week Low

HEALTHCARE

Sector

PLRZ Chart

Recent Chart
Price Action

PLRZ Technicals

Tags:

PLRZ Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -$118K
Total Revenue $0
Cost Of Revenue $118K
Costof Goods And Services Sold $118K
Operating Income -$1.3M
Selling General And Administrative $768K
Research And Development $534K
Operating Expenses $1.3M
Investment Income Net -
Net Interest Income -$28K
Interest Income -
Interest Expense $3K
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $118K
Income Before Tax -$1.5M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$1.5M
Comprehensive Income Net Of Tax -
Ebit -$1.5M
Ebitda -$1.4M
Net Income -$1.5M

Revenue & Profitability

Earnings Performance

PLRZ Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $5.5M
Total Current Assets $2.7M
Cash And Cash Equivalents At Carrying Value $2.6M
Cash And Short Term Investments $2.6M
Inventory -
Current Net Receivables -
Total Non Current Assets $2.9M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets $2.9M
Intangible Assets Excluding Goodwill $2.9M
Goodwill -
Investments -
Long Term Investments -
Short Term Investments $0
Other Current Assets $99K
Other Non Current Assets -
Total Liabilities $261K
Total Current Liabilities $261K
Current Accounts Payable -
Deferred Revenue -
Current Debt -
Short Term Debt -
Total Non Current Liabilities $0
Capital Lease Obligations -
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total -
Other Current Liabilities $261K
Other Non Current Liabilities -
Total Shareholder Equity $5.3M
Treasury Stock -
Retained Earnings -$5.1M
Common Stock -
Common Stock Shares Outstanding $3M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$1.1M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $118K
Capital Expenditures $0
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment $29K
Cashflow From Financing $3.7M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$1.5M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -$118K
Total Revenue $0
Cost Of Revenue $118K
Costof Goods And Services Sold $118K
Operating Income -$1.3M
Selling General And Administrative $768K
Research And Development $534K
Operating Expenses $1.3M
Investment Income Net -
Net Interest Income -$28K
Interest Income -
Interest Expense $3K
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $118K
Income Before Tax -$1.5M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$1.5M
Comprehensive Income Net Of Tax -
Ebit -$1.5M
Ebitda -$1.4M
Net Income -$1.5M

PLRZ News

PLRZ Profile

Polyrizon Ltd. Ordinary Shares Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Polyrizon Ltd. is an innovative biotech company based in Ra'anana, Israel, specializing in the development of medical device hydrogels designed for nasal spray applications. These cutting-edge hydrogels are aimed at enhancing drug delivery systems, positioning Polyrizon at the forefront of therapeutic advancements in nasal treatments. With a focus on addressing unmet medical needs, the company is leveraging its proprietary technology to potentially revolutionize the administration of medications and improve patient outcomes in the healthcare sector.

VHAI
+66.66%
$0.00
CGBS
-39.47%
$0.03
BITF
+28.33%
$5.39
UGRO
+71.96%
$0.63
BURU
-21.69%
$0.40
YYAI
-21.23%
$0.13
INTC
+2.33%
$37.22
QBTS
+23.01%
$40.61
SSKN
+48.00%
$2.27
ITP
+17.48%
$0.30
NVTS
+20.93%
$12.05
AXDX
-61.36%
$0.03
NVDA
-3.28%
$182.13
CAN
+13.81%
$1.73
EDHL
+79.75%
$0.89
BYND
-22.73%
$0.79
LAES
+17.31%
$7.19
MP
+21.34%
$95.06
PLUG
+0.38%
$3.91
IONQ
+16.19%
$82.09
MNTS
+23.03%
$1.75
CRML
+20.74%
$28.10
KDLY
-1.56%
$0.85
RGTI
-4.27%
$52.55
RMBL
+60.50%
$3.21
JDZG
+32.97%
$2.50
BULL
+2.98%
$11.74
ADD
-25.47%
$0.05
AMZN
+1.71%
$220.07
NAK
+2.63%
$2.73
IONZ
+10.03%
$2.53
SRM
+53.27%
$10.30
AMD
+1.83%
$220.40
DNN
-0.81%
$3.05
SMR
+14.72%
$45.02
UUUU
+6.41%
$25.29
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
TSLA
-2.60%
$424.55
DVLT
+7.57%
$1.82
BE
+26.52%
$109.91
WLGS
-5.57%
$0.04
ETHD
+11.40%
$3.70
TMQ
+10.62%
$6.56
GPUS
-9.48%
$0.38
UAMY
-0.26%
$16.66
ETWO
0.00%
$3.30
VZ
-0.25%
$39.75
NUAI
+35.36%
$3.18
USAR
-3.83%
$37.19
WULF
+8.50%
$15.19
AFMD
-34.94%
$0.18
CIFR
+0.19%
$20.38
ERIC
+17.07%
$9.56
ADAP
-15.26%
$0.15
WWR
+13.27%
$2.89
PLTR
+1.70%
$180.23
APLD
+5.70%
$36.19
OPI
-16.97%
$0.20
GWH
-9.09%
$8.22
AREC
+30.09%
$6.47
KLG
-9.05%
$13.35
NIO
-4.28%
$6.87
CORZ
+3.72%
$19.21
ABAT
+5.16%
$9.69
IREN
+2.41%
$65.69
GRYP
-10.38%
$1.38
GWAV
+89.77%
$16.14
SOFI
-0.46%
$27.01
SOUN
+3.78%
$19.86
MODV
-25.22%
$0.43
MARA
+3.65%
$20.98
TLRY
-3.84%
$1.62
ACHR
-5.12%
$12.11
BBD
+1.67%
$3.14
RGTZ
+5.16%
$9.77
ELAB
+83.43%
$9.55
FNB
+2.35%
$15.62
CLSK
+6.21%
$21.28
ATXS
+38.62%
$11.74
QS
-1.58%
$16.72
ONDS
-4.99%
$10.27
BMNR
-5.84%
$53.52
BMY
-0.95%
$43.54
NOK
+2.95%
$5.40
ASST
-5.54%
$1.02
F
+0.08%
$11.55
EXK
+10.96%
$8.50
PLTD
-1.00%
$6.91
BTBT
+0.75%
$4.03
VLY
+2.32%
$10.55
TBH
-48.33%
$1.24
DFLI
-1.68%
$1.54
NEHC
-9.61%
$2.35
SHOT
-74.37%
$0.39
EOSE
+2.05%
$17.39
RXRX
-3.79%
$5.32
GDXD
+1.06%
$0.74
NB
-3.88%
$10.88
ZAPP
-46.30%
$0.15
VHAI
+66.66%
$0.00
CGBS
-39.47%
$0.03
BITF
+28.33%
$5.39
UGRO
+71.96%
$0.63
BURU
-21.69%
$0.40
YYAI
-21.23%
$0.13
INTC
+2.33%
$37.22
QBTS
+23.01%
$40.61
SSKN
+48.00%
$2.27
ITP
+17.48%
$0.30
NVTS
+20.93%
$12.05
AXDX
-61.36%
$0.03
NVDA
-3.28%
$182.13
CAN
+13.81%
$1.73
EDHL
+79.75%
$0.89
BYND
-22.73%
$0.79
LAES
+17.31%
$7.19
MP
+21.34%
$95.06
PLUG
+0.38%
$3.91
IONQ
+16.19%
$82.09
MNTS
+23.03%
$1.75
CRML
+20.74%
$28.10
KDLY
-1.56%
$0.85
RGTI
-4.27%
$52.55
RMBL
+60.50%
$3.21
JDZG
+32.97%
$2.50
BULL
+2.98%
$11.74
ADD
-25.47%
$0.05
AMZN
+1.71%
$220.07
NAK
+2.63%
$2.73
IONZ
+10.03%
$2.53
SRM
+53.27%
$10.30
AMD
+1.83%
$220.40
DNN
-0.81%
$3.05
SMR
+14.72%
$45.02
UUUU
+6.41%
$25.29
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
TSLA
-2.60%
$424.55
DVLT
+7.57%
$1.82
BE
+26.52%
$109.91
WLGS
-5.57%
$0.04
ETHD
+11.40%
$3.70
TMQ
+10.62%
$6.56
GPUS
-9.48%
$0.38
UAMY
-0.26%
$16.66
ETWO
0.00%
$3.30
VZ
-0.25%
$39.75
NUAI
+35.36%
$3.18
USAR
-3.83%
$37.19
WULF
+8.50%
$15.19
AFMD
-34.94%
$0.18
CIFR
+0.19%
$20.38
ERIC
+17.07%
$9.56
ADAP
-15.26%
$0.15
WWR
+13.27%
$2.89
PLTR
+1.70%
$180.23
APLD
+5.70%
$36.19
OPI
-16.97%
$0.20
GWH
-9.09%
$8.22
AREC
+30.09%
$6.47
KLG
-9.05%
$13.35
NIO
-4.28%
$6.87
CORZ
+3.72%
$19.21
ABAT
+5.16%
$9.69
IREN
+2.41%
$65.69
GRYP
-10.38%
$1.38
GWAV
+89.77%
$16.14
SOFI
-0.46%
$27.01
SOUN
+3.78%
$19.86
MODV
-25.22%
$0.43
MARA
+3.65%
$20.98
TLRY
-3.84%
$1.62
ACHR
-5.12%
$12.11
BBD
+1.67%
$3.14
RGTZ
+5.16%
$9.77
ELAB
+83.43%
$9.55
FNB
+2.35%
$15.62
CLSK
+6.21%
$21.28
ATXS
+38.62%
$11.74
QS
-1.58%
$16.72
ONDS
-4.99%
$10.27
BMNR
-5.84%
$53.52
BMY
-0.95%
$43.54
NOK
+2.95%
$5.40
ASST
-5.54%
$1.02
F
+0.08%
$11.55
EXK
+10.96%
$8.50
PLTD
-1.00%
$6.91
BTBT
+0.75%
$4.03
VLY
+2.32%
$10.55
TBH
-48.33%
$1.24
DFLI
-1.68%
$1.54
NEHC
-9.61%
$2.35
SHOT
-74.37%
$0.39
EOSE
+2.05%
$17.39
RXRX
-3.79%
$5.32
GDXD
+1.06%
$0.74
NB
-3.88%
$10.88
ZAPP
-46.30%
$0.15
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.